Kaleido Biosciences in Research Collaboration with Janssen

Date : 01/09/2020 @ 1:58PM
Source : Dow Jones News
Stock : Johnson and Johnson (JNJ)
Quote : 123.16  -3.41 (-2.69%) @ 12:00AM
After Hours
Last Trade
Last $ 123.00 ▼ -0.16 (-0.13%)

Kaleido Biosciences in Research Collaboration with Janssen

Kaleido Biosciences (NASDAQ:KLDO)
Historical Stock Chart

3 Months : From Dec 2019 to Mar 2020

Click Here for more Kaleido Biosciences Charts.

By Michael Dabaie


Kaleido Biosciences Inc. (KLDO) said it initiated a research collaboration with Johnson & Johnson's (JNJ) Janssen Pharmaceutical Cos.

The companies will look at the potential for Kaleido's Microbiome Metabolic Therapies, or MMTs, to prevent the onset of childhood allergy and other atopic, immune and metabolic conditions. The agreement was facilitated by Johnson & Johnson Innovation, Kaleido said.

A primary focus of the research will be to utilize Kaleido's screening platform to identify MMTs candidates that support the growth of specific beneficial microbes. These MMTs will then be further evaluated for their ability to prevent atopic conditions such as infant allergy, Kaleido said.


Write to Michael Dabaie at michael.dabaie@wsj.com


(END) Dow Jones Newswires

January 09, 2020 08:43 ET (13:43 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Latest JNJ Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.